MICHAEL PAINTER: Open Payments
NPI 1164807178 · CLOVERDALE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,691 in 86 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,691
Food & beverage: $1,691
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $300 |
| Novo Nordisk Inc | 11 | $224 |
| Axsome Therapeutics, Inc. | 7 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $133 |
| Lilly USA, LLC | 6 | $108 |
| Astellas Pharma US Inc | 4 | $89 |
| Amgen Inc. | 5 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| Corium, LLC | 4 | $61 |
Products named: Auvelity, CAPLYTA, Rybelsus, VRAYLAR, REXULTI, Veozah, QULIPTA, JARDIANCE.
Industry payments across IN — which companies pay providers there.
